A needle in the 'cancer vaccine' haystack.
Gallois
Anne
A
Bhardwaj
Nina
N
D000818:Animals; D018949:Antigens, CD1; D000954:Antigens, Surface / Q000378:metabolism; D002138:Calibration; D019496:Cancer Vaccines / Q000276:immunology* / Q000627:therapeutic use; D045142:Cross-Priming / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology* / Q000378:metabolism / Q000502:physiology; D006023:Glycoproteins; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods* / Q000592:standards; D051379:Mice; D008954:Models, Biological; D018180:Thrombomodulin; D016896:Treatment Outcome
D018949:Antigens, CD1; D000954:Antigens, Surface; C437944:CD1C protein, human; D019496:Cancer Vaccines; D006023:Glycoproteins; C546931:THBD protein, human; D018180:Thrombomodulin